Solitary fibrous tumor (SFT) of prostate is an unusual type of mesenchymal neoplasm that can elicit a benign or malignant phenotype. It represents a diagnostic challenge as it can simulate poorly differentiated adenocarcinoma and various mesenchymal neoplasms of prostate. We report a case of prostate SFT in a 54-year-old patient, which was clinically misdiagnosed as nodular hyperplasia of prost...

Background: Benign prostatic hyperplasia is not a life threatening condition of men, but it often affects the quality in varying degrees. The success rate treating with conventional therapy limited, and physicians determine patient as candidate for surgery when medicinal approach fails. Though few case records are available past about homoeopathic medicines patients suffering from benign hyperp...

Benign Prostate Hyperplasia or in the medical fieldknown as BPH is a hyperplasia of prostate gland, causing enlargement gland.1Enlargement this organ will cause blockage posterior urethra that obstructs flow urine.2 In Indonesia, occurs 50% men with urinary tract stones.3 The prevalence increase age for people over 40 years old. For aged 60 old, BHP around 70% time and 80 possibility reaches 90...

Benign prostatic hyperplasia refers to an anatomic diagnosis, yet in practice it is typically diagnosed clinically on the basis of lower urinary tract symptoms and prostatic enlargement detected on manual rectal examination or transrectal ultrasonography (1). Over the past decade, since benign prostatic hyperplasia (2) and prostate cancer (3) were reviewed in this Journal, there has been a prol...

The present study investigated the role of androgen in the process of androgen-induced prostate hyperplasia in castrated rats and assessed the role of the phosphoinositide 3-kinase/protein kinase B/mechanistic target of rapamycin (PI3K/Akt/mTOR) pathway in this process. Furthermore, the extent to which autophagy may affect the level of androgen-induced benign prostatic hyperplasia was also expl...

Serum levels of adiponectin were measured in patients with benign prostatic hyperplasia and prostate cancer of pT2 and pT3 stage. Adiponectin ELISA assay, immunohistochemistry, and selected metabolic and biochemical parameters measurement was performed in 25 patients with benign prostatic hyperplasia and 43 with prostate cancer (17 patients with organ-confined and 26 patients with locally advan...

Prostatic hyperplasia (PH) is a common urologic disease that affects mostly elderly men. PH can be classified as benign prostatic hyperplasia (BPH), or prostate cancer (PCa) based on its severity. Oxidative stress (OS) is known to influence the activities of inflammatory mediators and other cellular processes involved in the initiation, promotion and progression of human neoplasms including pro...

Objective: To determine the diagnostic accuracy of PSA density in Prostate Cancer, Benign Prostatic Hyperplasia (BPH) and Prostatitis, taking biopsy as gold standard.
 Study Design: Cross-sectional study.
 Place Duration Study: Chemical Pathology Endocrinology Department, Armed Forces Institute (AFIP) collaboration with Histopathology department, AFIP, Urology (AFIU) Radiology (AFIRI)...

background: in order to use international prostate symptom score (ipss) in the iranian population, a valid and reliable persian version of this questionnaire is required. to date, this version of ipss with those characteristics is not available. material and methods: for evaluation of the validity, the original version of ipss (english version) was translated into persian and after 3 weeks was ...